Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.
- DOI
- 10.1093/infdis/jiag052
- Published
- 2026 Apr 29
- Container
- The Journal of infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/infdis/jiag052,
title = {Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.},
author = {Gafar F and Svensson EM and Yunivita V and Fregonese F and Fisher D and Fox GJ and Nguyen TA and Nguyen BH and Johnston J and Long R and Valiquette C and Aarnoutse RE and Ruslami R and Menzies D},
year = {2026},
journal = {The Journal of infectious diseases},
doi = {10.1093/infdis/jiag052},
url = {https://doi.org/10.1093/infdis/jiag052}
}RIS
TY - JOUR TI - Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial. AU - Gafar F AU - Svensson EM AU - Yunivita V AU - Fregonese F AU - Fisher D AU - Fox GJ AU - Nguyen TA AU - Nguyen BH AU - Johnston J AU - Long R AU - Valiquette C AU - Aarnoutse RE AU - Ruslami R AU - Menzies D PY - 2026 JO - The Journal of infectious diseases DO - 10.1093/infdis/jiag052 UR - https://doi.org/10.1093/infdis/jiag052 ER -
APA
F, G., EM, S., V, Y., F, F., D, F., GJ, F., TA, N., BH, N., J, J., R, L., C, V., RE, A., R, R., & D, M. (2026). Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiag052
Source records
- pubmed · retrieved 2026-09-25T12:11:43.587Z